Pioneering the Next Era of Global Health and Regenerative Therapeutics. Connecting 80 elite selected researchers across 20 countries.
Evaluating breakthrough medical science through elite peer-review pipelines.
The World Biomedical Innovation & Research Summit (WBIRS) 2025 stands as the pinnacle of academic selection under the strict governance of the World Medical Consortium. Out of thousands of scientific innovations submitted globally, only the most meticulous projects survived the evaluation matrix.
Each paper underwent a double-blind peer review phase handled by senior clinicians and medical specialists. This guaranteed absolute integrity, filtering out everything except the absolute vanguard of advanced tissue engineering, data analytics, and regenerative medicine.
Recognizing the highest echelon of innovative achievement at WBIRS 2025.
Universitas Sriwijaya
Indonesia
Grand Jury Evaluation: "A stellar presentation exhibiting deep clinical foresight, impeccable methodological soundness, and high potential for chairside translation. An absolute consensus winner."
The global roster of innovators representing top tier world universities.